A Phase 1a/1b Study of the pan-KRAS Inhibitor LY4066434 in Participants with KRAS Mutant Solid Tumors (J5Q-OX-JRDA)

Clinical Trial Grant

Duke Scholars

Principal Investigator John Strickler Medicine, Medical Oncology

Awarded By

Lilly USA, LLC

Start Date

March 18, 2025

End Date

March 31, 2030

Awarded By

Lilly USA, LLC

Start Date

March 18, 2025

End Date

March 31, 2030